LIA
NVO

Limestone Investment Advisors’s Novo Nordisk NVO Stock Holding History

Limestone Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
29,130
-27,380
-48% -$1.18M 0.1% 167
2026
Q1 		$2.08M Buy
56,510
+30,733
+119% +$1.46M 0.17% 101
2025
Q4 		$1.31M Sell
25,777
-12,016
-32% -$614K 0.13% 128
2025
Q3 		$2.1M Buy
37,793
+22,200
+142% +$1.3M 0.17% 106
2025
Q2 		$1.08M Buy
+15,593
New +$1.06M 0.09% 175

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Limestone Investment Advisors's NVO Position: Q2 2026 in Review

Limestone Investment Advisors reduced its Novo Nordisk (NVO) stake by 48% in Q2 2026, selling an estimated $1.18M and leaving 29,130 shares worth $1.4M. The position accounts for 0.1% of the portfolio, ranked #167.

Limestone Investment Advisors first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.1M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Limestone Investment Advisors held 29,130 shares of Novo Nordisk worth $1.4M as of Q2 2026.
  • Limestone Investment Advisors sold 27,380 Novo Nordisk shares in Q2 2026, an estimated $1.18M.
  • Novo Nordisk made up 0.1% of Limestone Investment Advisors's portfolio in Q2 2026, its #167 holding.
  • Limestone Investment Advisors first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Limestone Investment Advisors's Novo Nordisk position peaked at $2.1M in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Limestone Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.